Received: 12 December 2018
Accepted: 16 September 2019
First Online: 5 November 2019
: Not applicable. Corresponding authors who responded to interview questions provided written or verbal consent for their responses to be shared within this manuscript.
: Not applicable.
: The authors make the following declarations:JMF: I have worked for various Pharmaceutical companies as a consultant since January 2010 on compound specific clinical projects or cross-compound system-related projects. I have also entered a strategic alliance in January 2017 with d-Wise Inc. (North Carolina) where I contribute as an SME to the design and development of their data de-identification products. I am an appointed member of the European Medicines Agency Technical Anonymisation Group and Health Canada Stakeholder Reference Group on Public Release of Clinical Information. The views expressed within this research are my own.SJN: I have no known conflicts of interest. I am an appointed member of the European Medicines Agency Technical Anonymisation Group. The views expressed within this research are my own.